Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1790272
Max Phase: Preclinical
Molecular Formula: C47H69N13O11
Molecular Weight: 992.15
Molecule Type: Small molecule
Associated Items:
ID: ALA1790272
Max Phase: Preclinical
Molecular Formula: C47H69N13O11
Molecular Weight: 992.15
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H]1CCCN1)[C@@H](O)CC(=O)N[C@H](C(=O)N[C@H](C(N)=O)[C@H](C)O)[C@H](C)O
Standard InChI: InChI=1S/C47H69N13O11/c1-25(2)16-32(37(63)20-38(64)58-40(27(4)62)46(70)59-39(26(3)61)41(48)65)54-44(68)34(18-29-21-49-23-52-29)55-43(67)33(17-28-10-6-5-7-11-28)56-45(69)36-13-9-15-60(36)47(71)35(19-30-22-50-24-53-30)57-42(66)31-12-8-14-51-31/h5-7,10-11,21-27,31-37,39-40,51,61-63H,8-9,12-20H2,1-4H3,(H2,48,65)(H,49,52)(H,50,53)(H,54,68)(H,55,67)(H,56,69)(H,57,66)(H,58,64)(H,59,70)/t26-,27-,31+,32-,33-,34-,35-,36+,37-,39-,40-/m0/s1
Standard InChI Key: XPGCBPPRBWCDMH-XXWVDKRWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 992.15 | Molecular Weight (Monoisotopic): 991.5240 | AlogP: -3.14 | #Rotatable Bonds: 26 |
Polar Surface Area: 368.08 | Molecular Species: BASE | HBA: 14 | HBD: 13 |
#RO5 Violations: 3 | HBA (Lipinski): 24 | HBD (Lipinski): 14 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.33 | CX Basic pKa: 9.50 | CX LogP: -4.15 | CX LogD: -6.33 |
Aromatic Rings: 3 | Heavy Atoms: 71 | QED Weighted: 0.04 | Np Likeness Score: 0.12 |
1. Hui KY, Holtzman EJ, Quinones MA, Hollenberg NK, Haber E.. (1988) Design of rat renin inhibitory peptides., 31 (9): [PMID:3045320] [10.1021/jm00117a003] |
Source(1):